Penumbra, Inc Payments to Acquire Available-for-sale Securities
Penumbra, Inc (PEN) reported Payments to Acquire Available-for-sale Securities of $32.94 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2021-08-09
- Penumbra, Inc payments to acquire available-for-sale securities for the quarter ending 2021-06-30 was $20.67M, a 65.73% decline year-over-year.
- Penumbra, Inc payments to acquire available-for-sale securities for the quarter ending 2021-03-31 was $12.27M.
- Penumbra, Inc payments to acquire available-for-sale securities for the quarter ending 2020-12-31 was $33.05M, a 30.83% decline year-over-year.
- Penumbra, Inc payments to acquire available-for-sale securities for the quarter ending 2020-09-30 was $59.69M.
- Penumbra, Inc payments to acquire available-for-sale securities for fiscal 2020 was $153.06M, a 97.94% increase from fiscal 2019.
- Penumbra, Inc payments to acquire available-for-sale securities for fiscal 2019 was $77.33M, a 28.55% decline from fiscal 2018.
- Penumbra, Inc payments to acquire available-for-sale securities for fiscal 2018 was $108.23M, a 42.94% decline from fiscal 2017.
- Penumbra, Inc payments to acquire available-for-sale securities for fiscal 2017 was $189.66M, a 199.40% increase from fiscal 2016.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2021-06-30 | $20.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $32.94M 10-Q · filed 2021-08-09 | $65.99M derived: sum of 3 quarters · filed 2021-08-09 | $125.68M derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | $12.27M 10-Q · filed 2021-05-04 | $45.31M derived: sum of 2 quarters · filed 2021-05-04 | $105.01M derived: sum of 3 quarters · filed 2021-05-04 | $165.33M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-12-31 | $33.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $92.74M derived: sum of 2 quarters · filed 2021-02-23 | $153.06M derived: sum of 3 quarters · filed 2021-08-09 | $153.06M 10-K · filed 2021-02-23 |
| 2020-09-30 | $59.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $120.01M derived: sum of 2 quarters · filed 2021-08-09 | $120.01M 10-Q · filed 2020-11-02 | $167.79M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-06-30 | $60.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $60.32M 10-Q · filed 2021-08-09 | $108.10M derived: sum of 3 quarters · filed 2021-08-09 | $108.10M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-04 | $47.78M derived: sum of 2 quarters · filed 2021-05-04 | $47.78M derived: sum of 3 quarters · filed 2021-05-04 | $77.33M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $47.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $47.78M derived: sum of 2 quarters · filed 2021-02-23 | $77.33M derived: sum of 3 quarters · filed 2021-02-23 | $77.33M 10-K · filed 2021-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $29.55M derived: sum of 2 quarters · filed 2020-11-02 | $29.55M 10-Q · filed 2020-11-02 | $40.81M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $29.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $29.55M 10-Q · filed 2020-08-03 | $40.81M derived: sum of 3 quarters · filed 2021-02-23 | $76.28M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $11.26M derived: sum of 2 quarters · filed 2021-02-23 | $46.73M derived: sum of 3 quarters · filed 2021-02-23 | $65.67M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $11.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $46.73M derived: sum of 2 quarters · filed 2021-02-23 | $65.67M derived: sum of 3 quarters · filed 2021-02-23 | $108.23M 10-K · filed 2021-02-23 |
| 2018-09-30 | $35.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $54.42M derived: sum of 2 quarters · filed 2019-11-07 | $96.97M 10-Q · filed 2019-11-07 | $147.31M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $18.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $61.49M 10-Q · filed 2019-08-06 | $111.84M derived: sum of 3 quarters · filed 2020-02-26 | $160.77M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $42.55M 10-Q · filed 2019-05-07 | $92.89M derived: sum of 2 quarters · filed 2020-02-26 | $141.83M derived: sum of 3 quarters · filed 2020-02-26 | $187.43M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $50.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $99.27M derived: sum of 2 quarters · filed 2020-02-26 | $144.88M derived: sum of 3 quarters · filed 2020-02-26 | $189.66M 10-K · filed 2020-02-26 |
| 2017-09-30 | $48.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $94.54M derived: sum of 2 quarters · filed 2018-11-05 | $139.32M 10-Q · filed 2018-11-05 | $157.64M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $45.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $90.38M 10-Q · filed 2018-08-07 | $108.70M derived: sum of 3 quarters · filed 2019-02-26 | $126.26M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $44.78M 10-Q · filed 2018-05-08 | $63.10M derived: sum of 2 quarters · filed 2019-02-26 | $80.66M derived: sum of 3 quarters · filed 2019-02-26 | $98.59M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $35.88M derived: sum of 2 quarters · filed 2019-02-26 | $53.81M derived: sum of 3 quarters · filed 2019-02-26 | $63.35M 10-K · filed 2019-02-26 |
| 2016-09-30 | $17.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $35.50M derived: sum of 2 quarters · filed 2017-11-07 | $45.03M 10-Q · filed 2017-11-07 | $176.30M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $17.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $27.47M 10-Q · filed 2017-08-08 | $158.74M derived: sum of 3 quarters · filed 2018-02-27 | $158.74M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $9.53M 10-Q · filed 2017-05-09 | $140.80M derived: sum of 2 quarters · filed 2018-02-27 | $140.80M derived: sum of 3 quarters · filed 2018-02-27 | $142.46M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $131.27M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $131.27M derived: sum of 2 quarters · filed 2018-02-27 | $132.93M derived: sum of 3 quarters · filed 2018-02-27 | $135.34M 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.66M derived: sum of 2 quarters · filed 2016-11-03 | $4.07M 10-Q · filed 2016-11-03 | $6.64M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.07M 10-Q · filed 2016-08-09 | $6.64M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $2.41M 10-Q · filed 2016-05-09 | $4.98M derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $51.34M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $48.77M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $6.86M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |